| RS138775799 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS138776220 |
NUP205
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1387762631 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS138776588 |
MARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency, Charcot-Marie-Tooth disease axonal type 2U |
| RS138776684 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS138776960 |
MADD
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138777049 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS138777262 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1387778734 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1387780751 |
NALCN
|
Health Risk |
Likely pathogenic |
— |
| RS138778484 |
LMNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1387784932 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1387788860 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS138779023 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1387802849 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1387802855 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS138780791 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS138781159 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1387815998 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS138782455 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, CTNNA1-related disorder |
| RS138783302 |
XIAP
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked lymphoproliferative disease due to XIAP deficiency, Autoinflammatory syndrome |
| RS1387835815 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS138783896 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS138784081 |
SERPINH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 10, Osteogenesis imperfecta type 10 |
| RS138784430 |
WRAP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 3 |
| RS138784666 |
DIABLO
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 64, Autosomal dominant nonsyndromic hearing loss 64 |
| RS138784762 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Coffin-Siris syndrome |
| RS138785106 |
RASA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS138785249 |
MYRF
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138786388 |
STAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lipoid adrenal hyperplasia due to STAR deficency, STAR-related disorder |
| RS1387867750 |
USH1C
|
Health Risk |
Likely pathogenic |
— |
| RS1387872889 |
DSPP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138787321 |
BGN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1387875174 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS138787975 |
ATP13A4
|
Health Risk |
Conflicting classifications of pathogenicity |
ATP13A4-related disorder, ATP13A4-related disorder |
| RS138788183 |
ALDH4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperprolinemia type 2, ALDH4A1-related disorder |
| RS138788406 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS138789360 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS138789637 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Congenital stationary night blindness autosomal dominant 2 |
| RS138789658 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS138789938 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1387899682 |
STRADA
|
Health Risk |
Pathogenic |
Polyhydramnios, megalencephaly |
| RS138790252 |
GNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-D |
| RS1387903645 |
TCIRG1
|
Health Risk |
Pathogenic |
TCIRG1-related disorder, TCIRG1-related disorder |
| RS138791004 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, COL7A1-related disorder |
| RS138791086 |
KLHL40
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 8, Inborn genetic diseases |
| RS1387916046 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS138792258 |
PYCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, PYCR1-related disorder |
| RS138792819 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrochondrogenesis 1, COL11A1-related disorder |
| RS1387931144 |
RAB3GAP2
|
Health Risk |
Pathogenic |
— |
| RS138793555 |
IMPG2
|
Health Risk |
Pathogenic |
IMPG2-related disorder, IMPG2-related disorder |
| RS1387950081 |
CNP
|
Health Risk |
Pathogenic |
Myopia 2, autosomal dominant |
| RS138795531 |
SLC5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial renal glucosuria, Inborn genetic diseases |
| RS138796052 |
RAB3GAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Martsolf syndrome, Warburg micro syndrome 2 |
| RS138796072 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1387962158 |
SBDS
|
Health Risk |
Likely pathogenic |
Shwachman-Diamond syndrome 1, Shwachman-Diamond syndrome 1 |
| RS138796800 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, DBT-related disorder |
| RS138796822 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Nijmegen breakage syndrome-like disorder |
| RS138797058 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS138797097 |
BMPER
|
Health Risk |
Conflicting classifications of pathogenicity |
Diaphanospondylodysostosis, Diaphanospondylodysostosis |
| RS1387972965 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myopathy |
| RS138797911 |
CLPB
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylglutaconic aciduria, type VIIB |
| RS138798067 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS138799232 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS138800291 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCB11-related disorder, ABCB11-related disorder |
| RS138800446 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1388016179 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
KMT2A-related disorder, Wiedemann-Steiner syndrome |
| RS1388023086 |
AUH
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylglutaconic aciduria type 1, 3-methylglutaconic aciduria type 1 |
| RS138803413 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS138803628 |
SLC6A19
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138803855 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
USH2A-related disorder, Inborn genetic diseases |
| RS1388040238 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Usher syndrome |
| RS1388040598 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS138805251 |
DNMT3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS138805494 |
COCH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138808610 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS138808784 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
FAT2-related disorder, FAT2-related disorder |
| RS138809166 |
GPR143
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1388095672 |
NRXN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pitt-Hopkins-like syndrome 2, Inborn genetic diseases |
| RS138809906 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1388106856 |
GALE
|
Health Risk |
Likely pathogenic |
UDPglucose-4-epimerase deficiency, Thrombocytopenia 13 |
| RS138810908 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Hyper-IgE recurrent infection syndrome 3 |
| RS138811155 |
PCDH12
|
Health Risk |
Conflicting classifications of pathogenicity |
Diencephalic-mesencephalic junction dysplasia syndrome 1, Inborn genetic diseases |
| RS138811990 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS138812333 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 11, Dilated cardiomyopathy 1R |
| RS138812345 |
PPP1R3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Monogenic diabetes |
| RS138812517 |
ARSH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138812566 |
ACE
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, ACE-related disorder |
| RS138812846 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS1388128874 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1388130536 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia |
| RS138814793 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 2, primary |
| RS1388158419 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS138815960 |
ZMYND10
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 22, Kartagener syndrome |
| RS138816053 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Occult macular dystrophy, Retinal dystrophy |
| RS1388161283 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS138816491 |
LAMB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMB2-related infantile-onset nephrotic syndrome |
| RS138817140 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1388177618 |
EYS
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1388178333 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Heimler syndrome 2 |